Sana Biotechnology Inc vs Union Pacific Corporation — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Union Pacific Corporation trades at $295.68 (market cap $175.89B). The key difference: Union Pacific Corporation is far larger — about 201.3× Sana Biotechnology Inc's market cap, and Union Pacific Corporation pays a 1.86% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | UNP | |
|---|---|---|
Market Cap | $873.84M | $175.89B |
Sector | Health | Industrials |
52-Week High | $5.92 | $301.75 |
52-Week Low | $2.68 | $214.91 |
Enterprise Value | $848.03M | $206.36B |
Dividend Yield | — | 1.86% |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →